We first searched for known meningioma driver mutations in each sample, defining the distribution of benign versus atypical meningiomas in each of the molecular subgroups including NF2, TRAF7 (co-mutated with PI3K pathway or KLF4), Hedgehog and POLR2A mutant tumours. The gene discussed is NF2; the disease is meningioma.